Yan Feng
Net worth: 228 M $ as of 30/06/2026
Net worth: 228 M $ as of 30/06/2026
Yan Feng is the founder of Fujian Haixi New Drug Creation Co., Ltd., founded in 2012, serving as Executive Director & Deputy General Manager since 2024.
Ms. Feng currently works at Yale School of Medicine as a Research Manager since 2009.
Formerly, Ms. Feng was Lab Director at McMaster University from 2003 to 2009.
Ms. Feng completed graduate studies at the Chinese Academy of Sciences in 2002 and undergraduate studies at Lanzhou University in 1997.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/06/2026 | 9,918,426 ( 12.6% ) | 228 M $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| FUJIAN HAIXI PHARMACEUTICALS CO., LTD. | Founder | 27/03/2012 |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Chief Tech/Sci/R&D Officer | 01/09/2009 |
| Companies | Position | End |
|---|---|---|
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/07/2009 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinese Academy of Sciences
Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lanzhou University
Lanzhou University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fujian Haixi New Drug Creation Co., Ltd
Fujian Haixi New Drug Creation Co., Ltd BiotechnologyHealth Technology Engages in research, development, production and sale of pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions